These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 8765464

  • 21. Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range.
    Balment RJ, Brimble MJ, Forsling ML, Musabayane CT.
    J Physiol; 1984 Jul; 352():517-26. PubMed ID: 6747899
    [Abstract] [Full Text] [Related]

  • 22. Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
    Saad WA, Camargo LA, Antunes-Rodrigues J, Saad WA, Guarda IF, Guarda RS.
    Regul Pept; 2005 Dec 15; 132(1-3):53-8. PubMed ID: 16198010
    [Abstract] [Full Text] [Related]

  • 23. The effect of indomethacin on the renal response to arginine vasopressin in man.
    Dixey JJ, Williams TD, Lightman SL, Lant AF, Brewerton DA.
    Clin Sci (Lond); 1986 May 15; 70(5):409-16. PubMed ID: 3457670
    [Abstract] [Full Text] [Related]

  • 24. Effects of neurohypophyseal antagonists in postnephrectomy natriuresis in male rats.
    Huang W, Lee SL, Sjöquist M.
    Kidney Int; 1994 Mar 15; 45(3):692-9. PubMed ID: 8196272
    [Abstract] [Full Text] [Related]

  • 25. V(1) receptors in luminal action of vasopressin on distal K(+) secretion.
    Amorim JB, Malnic G.
    Am J Physiol Renal Physiol; 2000 May 15; 278(5):F809-16. PubMed ID: 10807593
    [Abstract] [Full Text] [Related]

  • 26. Stimulation of rat renal medullary Na+/K(+)-ATPase by arginine vasopressin is mediated by the V2 receptor.
    Charlton JA, Baylis PH.
    J Endocrinol; 1990 Nov 15; 127(2):213-6. PubMed ID: 2174453
    [Abstract] [Full Text] [Related]

  • 27. Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260).
    Burrell LM, Phillips PA, Stephenson JM, Risvanis J, Johnston CI.
    Blood Press; 1994 Mar 15; 3(1-2):137-41. PubMed ID: 8199714
    [Abstract] [Full Text] [Related]

  • 28. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene.
    Yokoi H, Nagasaki H, Tachikawa K, Arima H, Murase T, Miura Y, Hirabayashi M, Oiso Y.
    J Endocrinol; 2002 Apr 15; 173(1):23-33. PubMed ID: 11927381
    [Abstract] [Full Text] [Related]

  • 29. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
    Yamamoto T, Kimura T, Ota K, Shoji M, Inoue M, Sato K, Ohta M, Yoshinaga K.
    Am J Physiol; 1992 Jun 15; 262(6 Pt 1):E856-62. PubMed ID: 1535483
    [Abstract] [Full Text] [Related]

  • 30. Effect of AVP.V1-receptor antagonist on urinary albumin excretion and renal hemodynamics in NIDDM nephropathy: role of AVP.V1-receptor.
    Yamada K, Nakano H, Nishimura M, Yoshida S.
    J Diabetes Complications; 1995 Jun 15; 9(4):326-9. PubMed ID: 8573758
    [Abstract] [Full Text] [Related]

  • 31. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    Naitoh M, Suzuki H, Murakami M, Matsumoto A, Ichihara A, Nakamoto H, Yamamura Y, Saruta T.
    Am J Physiol; 1993 Oct 15; 265(4 Pt 2):R934-42. PubMed ID: 8238468
    [Abstract] [Full Text] [Related]

  • 32. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
    Ledderhos C, Mattson DL, Skelton MM, Cowley AW.
    Am J Physiol; 1995 Mar 15; 268(3 Pt 2):R796-807. PubMed ID: 7900923
    [Abstract] [Full Text] [Related]

  • 33. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G, De Wied D.
    Brain Res; 1997 Jun 06; 759(1):18-23. PubMed ID: 9219858
    [Abstract] [Full Text] [Related]

  • 34. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS.
    Methods Find Exp Clin Pharmacol; 1994 Jun 06; 16(5):315-21. PubMed ID: 7934310
    [Abstract] [Full Text] [Related]

  • 35. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG, Ross MG, Leake RD, Fisher DA.
    Am J Physiol; 1992 Apr 06; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [Abstract] [Full Text] [Related]

  • 36. Modulation of the effect of arginine-vasopressin on water and ion transport in the newt early distal tubule and frog urinary bladder by V1-antagonists.
    Goncharevskaya OA, Shakhmatova EI, Natochin YV.
    Pflugers Arch; 1995 Oct 06; 430(6):1004-11. PubMed ID: 8594534
    [Abstract] [Full Text] [Related]

  • 37. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors.
    Kasson BG, Hsueh AJ.
    Endocrinology; 1986 Jan 06; 118(1):23-31. PubMed ID: 3000735
    [Abstract] [Full Text] [Related]

  • 38. Pretreatment with vasodilator or V1-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats.
    Chiu EK, McNeill JR.
    J Hypertens; 1987 Oct 06; 5(5):593-8. PubMed ID: 2963065
    [Abstract] [Full Text] [Related]

  • 39. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R, Chiarenza A, Kamilaris TC, Renaud N, Lempereur L, Demitrack M, Gold PW, Chrousos GP.
    Neuroendocrinology; 1994 Nov 06; 60(5):503-8. PubMed ID: 7845540
    [Abstract] [Full Text] [Related]

  • 40. Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor.
    Yang XD, Zhao LY, Zheng QS, Li X.
    J Cardiovasc Pharmacol; 2003 Jul 06; 42(1):132-5. PubMed ID: 12827038
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.